生物活性 | |||
---|---|---|---|
描述 | Alogliptin Benzoate (SYR-322) is a potent, selective, and orally active DPP-4 inhibitor with an IC50 of less than 10 nM, showing over 10,000-fold selectivity against DPP-8 and DPP-9. It is used in research related to type 2 diabetes[1].[2].[3]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02798172 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | - |
NCT01990300 | - | Completed | - | - | |
NCT03499704 | Diabetes Mellitus, Type 2 | Phase 4 | Not yet recruiting | December 31, 2020 | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.17mL 0.43mL 0.22mL |
10.83mL 2.17mL 1.08mL |
21.67mL 4.33mL 2.17mL |
参考文献 |
---|